Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia [2] (multiple letters)

Blood

Volumn 94, Issue 10, 1999, Pages 3609-3611

  Moravcova, J ^a   Nadvornikova, S ^a   Lukasova, M ^a   Klamova, H ^a   Faderl, S ^a   Talpaz, M ^a   Kantarjian, H M ^a   Estrov, Z ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

CANCER RECURRENCE; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; HUMAN; LABORATORY DIAGNOSIS; LETTER; MEDICAL DECISION MAKING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RISK ASSESSMENT;

EID: 0033571366     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.10.3609.422a38b_3609_3611     Document Type: Letter

References (0)